Research / IMKTA / Fundamental state Inspectable configuration
State dimensions Filing 0000050493-26-000020 General Corporate
Debt relative to revenue 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
36.58% · OPTIONAL · VALID
Capex intensity 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.71% · OPTIONAL · VALID
Operating cash generation 50th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.90% · OPTIONAL · VALID
Revenue growth 55th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
1.64% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
35.05% · OPTIONAL · VALID
Gross margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
24.30% · CORE · VALID
Operating margin 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
2.52% · CORE · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 25 states Self-history eligible
Sep 25, 2021 0/7 normalized Level 3 Dec 25, 2021 0/7 normalized Level 3 Mar 26, 2022 0/7 normalized Level 3 Jun 25, 2022 6/7 normalized Level 3 Sep 24, 2022 6/7 normalized Level 3 Dec 24, 2022 6/7 normalized Level 3 Mar 25, 2023 6/7 normalized Level 3 Jun 24, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 30, 2023 7/7 normalized Level 3 Mar 30, 2024 7/7 normalized Level 3 Jun 29, 2024 7/7 normalized Level 3 Sep 28, 2024 7/7 normalized Level 3 Dec 28, 2024 7/7 normalized Level 3 Mar 29, 2025 7/7 normalized Level 3 Jun 28, 2025 7/7 normalized Level 3 Sep 27, 2025 7/7 normalized Level 3 Dec 27, 2025 7/7 normalized Level 3 Mar 28, 2026 7/7 normalized Level 3 Jun 27, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 38.52%
Current 36.58%
Delta -1.94% Capex Intensity Increased
Previous 1.27%
Current 1.71%
Delta 0.43% Cash Generation Decreased
Previous 6.41%
Current 4.90%
Delta -1.51% Growth Increased
Previous -1.76%
Current 1.64%
Delta 3.40% Inventory Pressure Decreased
Previous 36.66%
Current 35.05%
Delta -1.60% Margin Decreased
Previous 24.87%
Current 24.30%
Delta -0.57% Profitability Decreased
Previous 2.64%
Current 2.52%
Delta -0.12% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Dec 27, 2025
Similarity 83%
Compared 7 dimensions
Coverage 100% Growth 6.1 · Margin 5.0 · Profitability 10.0 · Capex Intensity 25.0 · Cash Generation 35.0 · Inventory Pressure 10.0 · Balance Sheet Leverage 5.0 Jun 28, 2025
Similarity 81%
Compared 7 dimensions
Coverage 100% Growth 42.5 · Margin 5.0 · Profitability 0.0 · Capex Intensity 10.0 · Cash Generation 10.0 · Inventory Pressure 15.0 · Balance Sheet Leverage 15.0 Mar 30, 2024
Similarity 69%
Compared 7 dimensions
Coverage 100% Growth 45.9 · Margin 55.0 · Profitability 15.0 · Capex Intensity 18.3 · Cash Generation 3.3 · Inventory Pressure 25.0 · Balance Sheet Leverage 21.7 Jun 25, 2022
Similarity 66%
Compared 6 dimensions
Coverage 86% Margin 55.0 · Profitability 22.5 · Capex Intensity 35.0 · Cash Generation 25.0 · Inventory Pressure 37.5 · Balance Sheet Leverage 0.0 Mar 25, 2023
Similarity 65%
Compared 6 dimensions
Coverage 86% Margin 55.0 · Profitability 15.0 · Capex Intensity 21.4 · Cash Generation 50.0 · Inventory Pressure 25.0 · Balance Sheet Leverage 20.5 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.